Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

After Layoffs, Santarus Thrives Due To Its Culture
investors.com
Saturday, June 1, 2013 - 12:02pm
tags:
Santarus
MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes
Yahoo
Friday, May 31, 2013 - 4:37pm
tags:
type 1 diabetes, MannKind, Afrezza, inhaled insulin
After Layoffs, Santarus Thrives Due To Its Culture
Investors.com
Friday, May 31, 2013 - 4:34pm
tags:
layoffs, Santarus
Masimo throws down the gauntlet with $1M challenge against Covidien
Mass Device
Friday, May 31, 2013 - 1:02pm
tags:
Masimo, Covidien, devices, pulse oximetry, nellcor
Vanda files for approval of sleep disorder drug
Yahoo/AP
Friday, May 31, 2013 - 1:01pm
tags:
Vanda, tasimelteon
The Arena Pipeline Potential
Seeking Alpha
Friday, May 31, 2013 - 12:59pm
tags:
Arena Pharmaceuticals, Belviq, Vivus, APD811, pulmonary hypertension, Termanogrel, deep vein thrombosis, APD334, autoimmune disease
The Race For Oral HCV?
Seeking Alpha
Friday, May 31, 2013 - 12:57pm
tags:
AbbVie, Gilead, JNJ, Merck, Vertex Pharmaceuticals, hepatitis C
Will Hepatitis C Become The Next Battleground Over Compulsory Licenses?
Pharmalot
Friday, May 31, 2013 - 12:43pm
tags:
hepatitis C, compulsory licenses
PharmAthene will proceed with anthrax vaccine test
Bloomberg/AP
Friday, May 31, 2013 - 12:37pm
tags:
vaccines, PharmAthene, anthrax, SparVax
Cancer Immunotherapy the Top Focus at ASCO
CNBC
Friday, May 31, 2013 - 12:31pm
tags:
ASCO, immunotherapy, cancer, Bristol-Myers Squibb, Roche, and Merck
The Future Of Omega-3 Based Lipid Management: All Eyes On Amarin
Seeking Alpha
Friday, May 31, 2013 - 12:29pm
tags:
Amarin, Vascepa, AstraZeneca, GSK, Neptune Technologies & Bioresources
Pfizer Prevenar 13 gets EMA recommendation for extension of indication
Yahoo/Fly on the Wall
Friday, May 31, 2013 - 11:44am
tags:
Pfizer, Prevenar 13, Europe
Can Abbott Laboratories Maintain the Lead?
Wall St. Cheat Sheet
Friday, May 31, 2013 - 11:23am
tags:
Abbott Laboratories
4 Investment Opportunities in Animal Health
Motley Fool
Friday, May 31, 2013 - 11:21am
tags:
animal health, Zoetis, Merial, Sanofi, Pfizer, Merck Animal Health, Eli Lilly, Merck, Elanco
Picking A Winner In The Pfizer-Zoetis Divorce
Seeking Alpha
Friday, May 31, 2013 - 11:11am
tags:
animal health, Pfizer, Zoetis
Orphan Drug Status for Astellas' Candidate
Yahoo/Zacks
Friday, May 31, 2013 - 9:36am
tags:
orphan drugs, Astellas, invasive aspergillosis, isavuconazole
[video]3 Amgen Biologics Facing Generic Competition
Motley Fool
Friday, May 31, 2013 - 9:28am
tags:
Amgen, generics, Aranesp, Epogen, Neupogen
Two FDA Officials Quarrel Over Safety Of Angiotensin Receptor Blockers
Forbes
Friday, May 31, 2013 - 9:17am
tags:
ARBs, Forbes
Takeda, Biogen, Article One: Intellectual Property
Bloomberg
Friday, May 31, 2013 - 9:07am
tags:
Takeda, Biogen Idec, intellectual property, Novartis, Dexilant, generics, Sandoz, Tecfidera, Impax Laboratories
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
NY Times, NY
Thursday, May 30, 2013 - 4:51pm
tags:
physicians, diabetes, Bristol-Myers Squibb, Byetta, Merck, AstraZeneca, Januvia, Novo Nordisk, Eli Lilly, Takeda, Boehringer Ingelheim

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.